Detrimental effects of nitric oxide inhibition on hepatic encephalophathy in rats with thioacetamide-induced fulminant hepatic failure

European Journal of Clinical Investigation

Volumn 31, Issue 2, 2001, Pages 156-163

  Chu, C J ^a   Wang, S S ^a   Lee, F Y ^a   Chang, F Y ^a   Lin, H C ^a   Hou, M C ^a   Chan, C C ^a   Wu, S L ^a   Chen, C T ^a   Huang, H C ^a   Lee, S D ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Endotoxin; Fulminant hepatic failure; Hepatic encephalopathy; Nitric oxide; Thioacetamide; Tumour necrosis factor

Indexed keywords

ENDOTOXIN; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; THIOACETAMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; COLORIMETRY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATIC COMA; HEPATIC ENCEPHALOPATHY; LIMULUS LYSATE TEST; LIVER FAILURE; MALE; MENTAL DISEASE; MORTALITY; MOTOR ACTIVITY; NONHUMAN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT; SCORING SYSTEM; VASODILATATION;

ANIMALS; ENDOTOXINS; HEPATIC ENCEPHALOPATHY; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; THIOACETAMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035102097     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2001.00775.x     Document Type: Article

References (53)

1. Hepatic encephalopathy
2. Fulminant hepatic failure
3. Current theories on the pathogenesis of hepatic encephalopathy
4. Vascular endothelial cells synthesize nitric oxide from L-arginine
5. Effects of inhibiting nitric oxide synthase on the systemic and splanchnic circulation of rats with portal hypertension
6. N-nitro-L-argninine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats
7. Hyperdynamic circulation of liver disease 40 years later: Pathophysiology and clinical consequences
8. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy
9. Regulation of blood-brain barrier endothelial cells by nitric oxide
10. 2formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis
11. Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure
12. Cerebral blood flow autoregulation is absent in rats with fulminant hepatic failure
13. Cerebral hemodynamic and changes in fulminant hepatic failure: A retrospective study
14. Hemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension
15. Activation of arginine metabolism to glutamate in rat brain synaptosomes in thioacetamide-induced hepatic encephalopathy: An adaptive response?
16. Effect of acute thioacetamide administration on brain phospholipid metabolism
17. A-benzodiazepine receptor on hepatic encephalopathy in the rat: Comparison with uremic encephalopathy
18. Brain monoamine metabolism and hehaviour in portacaval shunted rats
19. Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats
20. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat
21. Nitric oxide production by monocytes in alcoholic liver disease
22. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands
23. Endotoxemia in patients with chronic liver disease: Relationship to the severity of liver disease, presence of esophageal varices, and hyperdynamic circulation
24. Chromogenic endotoxin assay in plasma selection of plasma pretreatment and production of standard curves
25. The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protects rats against thioacetamide-induced fulminant hepatic failure
26. Uptake by liver cells of endotoxin following its intravenous injection
27. Endotoxemia, encephalopathy and mortality in cirrhotic patients
28. Relation of renal impairment and hemorrhagic diathesis to endotoxemia in fulminant hepatic failure
29. Tumor necrosis factor (TNF)
30. Effects of cytokines on the liver
31. Endotoxin-induced changes in nitrogen metabolism
32. Gamma-aminobutyric acid (GABA) production by eight common bacterial pathogens
33. 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-α and lipopolysaccharide
34. Amino acid derangement in patients with sepsis: Treatment with branched chain amino acid rich infusions
35. Nitric oxide: Physiology, pathophysiology and pharmacology
36. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo
37. Involvement and dual effects of nitric oxide in septic shock
38. Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride
39. Inhibition of nitric oxide synthase improves liver damage and reduced mortality in a characterized model of thioacetamide-induced fulminant hepatic failure
40. In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitors
41. Protective roles of nitric oxide and testosterone in endotoxemia: Evidence from NOS-2-deficient mice
42. Nitric oxide in liver injury
43. Evidence for the inhibitory role of guanosine 3′,5′ monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators
44. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation
45. Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes
46. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia
47. Role of nitric oxide in oxygen transport in rat liver sinusoids during endotoxemia
48. Inhibition of nitric oxide synthesis in experimental gram-negative sepsis
49. 3H]arginine uptake in brain following portacaval anastomosis
50. Increased neuronal nitric oxide synthase expression in brain following portacaval anastomosis
51. Acute liver failure and hyperammonemia increased nitric oxide synthase in mouse brain
52. Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication
53. Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication